|
시장보고서
상품코드
2021161
압박 요법 시장 규모 및 예측(2021-2034년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 - 제품별, 기술별, 용도별, 최종사용자별, 지역별Compression Therapy Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Technology; Application, End User, and Geography |
||||||
압박 요법 시장은 2025년 23억 9,000만 달러에서 2034년까지 34억 4,000만 달러로 성장할 것으로 예측됩니다. 2026-2034년에 이 시장은 CAGR 4.2%를 기록할 것으로 전망되고 있습니다. 압박 치료 시장의 성장은 정맥 및 림프계 질환의 유병률 증가, 기술 발전과 신제품 혁신, 고령화 및 만성질환의 증가로 인해 치료법 채택이 증가함에 따라 압축 치료 시장의 성장에 기인하고 있습니다.
압박 요법은 일반적으로 옷, 붕대 또는 기구를 사용하여 조절된 압력을 가하여 환부의 혈액 순환과 림프 흐름을 개선하는 의료 시술입니다. 정맥류, 림프부종, 심부정맥혈전증, 만성정맥부전 등의 증상 관리에 널리 사용되고 있습니다. 점진적으로 압력을 가하면 부종을 줄이고 체액 저류를 방지하며 정맥 환류를 촉진하는 데 도움이 됩니다. 압박 요법은 병원, 클리닉, 재택 치료 현장에서 일반적으로 사용되며, 수술 후 회복, 상처 치유 및 만성 혈관 질환의 장기 관리에 중요한 역할을 합니다.
북미 압박요법 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국의 압박요법 시장은 혈관 및 림프계 질환의 높은 유병률, 보험 적용 범위 확대, 지속적인 임상적 혁신으로 인해 확대되고 있습니다. 미국 질병예방통제센터(CDC)에 따르면 심부정맥혈전증(DVT)과 폐색전증을 포함한 정맥혈전색전증(VTE)은 연간 최대 90만 명의 미국인에게 영향을 미치며, 그 중 상당수는 압박 요법과 같은 기계적 조치로 예방할 수 있다고 합니다. 이는 임상적 관리가 필요한 고위험군 인구가 다수 존재한다는 것을 의미합니다. 또한 압박 제품의 주요 적응증인 만성정맥부전(CVI)은 미국 성인의 10%-35%가 앓고 있는 것으로 추정되며, 정맥궤양과 같은 합병증은 고령자에게서 많이 발생합니다. 림프부종도 여전히 널리 퍼져 있으며, 최소 500만 명의 미국인이 이 질환을 앓고 있으며, 메디케어-메디케이드 서비스 센터(CMS)에 따르면 2024년부터는 약 절반이 의사의 처방에 따라 압박복과 용품에 대해 메디케어 파트 B의 적용을 받을 수 있다고 합니다.
2024년 1월 1일부터 시행되는 '림프부종 치료법' 등 처방된 압박치료용품에 대한 메디케어 적용을 의무화하는 정책 변경으로 급여 범위가 확대되고 수급자의 비용 부담이 경감됨에 따라 의료인의 처방 증가와 환자 수용이 촉진되고 있습니다. 임상적 측면에서는 2025년에 업데이트될 HCPCS 코드의 확장으로 다양한 압박복에 대한 상세한 청구가 가능해져 의료진의 접근성과 참여가 촉진될 것으로 보입니다. 한편, 의료기기의 발전도 계속되고 있으며, 의료기기 제조업체는 임상 현장과 재택 간호의 요구를 충족시키기 위해 차세대 공압식 압박 시스템과 개선된 의류 디자인을 도입하고 있습니다. 이러한 역학적 요인, 정책적 요인, 제품 혁신 요인이 결합되며, 2023-2025년까지 미국 의료 현장 전반에서 압박 요법에 대한 수요 증가를 지원하고 있습니다.
정부 주도의 보험 적용 및 상환 확대로 미래 시장 기회 창출
압박 요법의 중요한 기회는 의학적으로 처방된 압박 제품에 대한 보험 적용을 확대하는 공중 보건 정책의 변화에서 비롯되며, 이는 경제적 장벽을 낮추고 임상 현장에서의 채택을 더욱 촉진할 것으로 예상됩니다. 예를 들어 미국 림프부종 치료법(H.R. 3630)이 제정되어 메디케어 규정이 개정되었습니다. 이에 따라 2024년부터 림프부종에 의학적으로 필요한 단계별 압박복 및 관련 치료 툴이 메디케어 프로그램 적용을 받게 됩니다. 의회의 법안 문구에 따르면 이 적용 범위는 자격을 갖춘 임상의가 처방한 경우 표준 압박 요법 용품 및 맞춤형 압박 요법 용품 모두에 적용되며, 지금까지 이러한 필수 용품의 자부담 비용에 직면했던 수백만 명의 수혜자의 접근성이 개선될 것으로 예상됩니다.
이번 법 개정은 만성 림프계 질환 환자들의 본인 부담금을 경감시킬 뿐만 아니라, 메디케이드와 민간 보험사들에게도 선례가 되어 보다 광범위한 계층으로 적용 범위가 확대될 가능성이 있습니다. 의료 서비스 제공자와 제조업체는 보다 예측 가능한 상환을 통해 제품 혁신과 임상 교육 노력에 더 많은 확신을 가지고 투자할 수 있으며, 이는 표준 만성질환 관리 프로세스에서 압박 치료 솔루션의 채택을 확대하는 데 도움이 될 것입니다.
목차
제1장 개요
제2장 압박 요법 시장 구도
제3장 경쟁 구도
제4장 압박 요법 시장 - 주요 시장 역학
제5장 압박 요법 시장 - 세계 시장 분석
제6장 압박 요법 시장의 매출 분석 - 제품별
제7장 압박 요법 시장의 매출 분석 - 기술별
제8장 압박 요법 시장의 매출 분석 - 용도별
제9장 압박 요법 시장의 매출 분석 - 최종사용자
제10장 압박 요법 시장 - 지역 분석
제11장 압박 요법 시장의 업계 상황
제12장 압박 요법 시장 - 주요 기업 개요
제13장 분석 대상 기타 기업 리스트
제14장 부록
KSA 26.05.12The Compression Therapy market is anticipated to grow from US$ 2.39 Billion in 2025 to US$ 3.44 Billion by 2034; the market is expected to register a CAGR of 4.2% from 2026 to 2034. Compression Therapy Market growth is attributed to the rising prevalence of venous and lymphatic disorders driving therapy adoption, increasing technological advancements and new product innovations, and aging populations and increasing chronic disease.
Compression therapy is a medical treatment that uses controlled pressure, typically through garments, bandages, or devices, to improve blood circulation and lymphatic flow in affected areas. It is widely used to manage conditions such as varicose veins, lymphedema, deep vein thrombosis, and chronic venous insufficiency. By applying graduated pressure, it helps reduce swelling, prevent fluid buildup, and enhance venous return. Compression therapy is commonly used in hospitals, clinics, and home care settings, and plays a key role in post-surgical recovery, wound healing, and long-term management of chronic vascular conditions.
The compression therapy market in North America is segmented into the US, Canada, and Mexico. The US compression therapy market is expanding due to high and sustained prevalence of vascular and lymphatic conditions, evolving policy coverage, and continued clinical innovation. According to the CDC, venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, affects up to 900,000 Americans annually, with many cases preventable through mechanical measures like compression therapy, highlighting a large at-risk population requiring clinical management. Additionally, chronic venous insufficiency (CVI), a major indication for compression products, is estimated to affect between 10% and 35% of US adults, with complications such as venous ulcers more common in older adults. Lymphedema also remains prevalent, with at least five million Americans living with the condition, and roughly half of them covered under Medicare Part B starting in 2024 for medically prescribed compression garments and supplies, according to the Centers for Medicare & Medicaid Services (CMS).
Policy changes such as the implementation of the Lymphedema Treatment Act beginning January 1, 2024, mandating Medicare coverage for prescribed compression treatment items, have expanded reimbursement and reduced cost barriers for beneficiaries, encouraging higher clinician prescriptions and patient uptake. Clinically, updated HCPCS coding expansions in 2025 support detailed billing for diverse compression garments, improving access and provider participation. Meanwhile, device advancements continue, with healthcare manufacturers introducing next-generation pneumatic compression systems and improved garment designs to address both clinical and home care needs. These combined epidemiological, policy, and product innovation factors underpin the growing demand for compression therapy across US healthcare settings in 2023-2025.
Government Driven Coverage & Reimbursement Expansion to Provide Market Opportunities in Future
An important opportunity for compression therapy stems from public health policy changes that improve insurance coverage for medically prescribed compression products, reducing financial barriers and driving wider clinical adoption. For example, the US Lymphedema Treatment Act (H.R. 3630) was enacted to amend Medicare rules so that medically necessary gradient compression garments and related treatment items prescribed for lymphedema are covered under the Medicare program starting in 2024. According to the Congressional text, this coverage applies to both standard and custom-fitted compression therapy items when prescribed by a qualified clinician, which is expected to improve access for millions of beneficiaries who previously faced out-of-pocket costs for these essential supplies.
This legislative shift not only reduces out-of-pocket burden for patients with chronic lymphatic conditions but also sets a precedent for Medicaid and private insurers to follow, potentially expanding coverage across wider populations. As reimbursement becomes more predictable, healthcare providers and manufacturers can invest in product innovations and clinical education initiatives with greater confidence, driving higher adoption of compression therapy solutions in standard chronic disease management pathways.
World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Chemical Society Publications, The U.S. Centers for Medicare & Medicaid Services (CMS), The Longitudinal Ageing Study of India (LASI), Centers for Medicare & Medicaid Services (CMS), National Center for Biotechnology Information (NCBI). National Institutes of Health (NIH). the US Food and Drug Administration, Mexican government health surveys (ENSANUT), Institut national de la statistique et des etudes economiques (INSEE), Istituto Superiore di Sanita (ISS) PASSI surveillance, Eurostat, the Italian Ministry of Health and ISS care pathway guidelines, United Nations Economic and Social Commission for Asia and the Pacific (UN ESCAP), China's National Health Commission statistics, the Ministry of Health, Labour and Welfare (MHLW), the Indian Council of Medical Research's (ICMR), Korea National Health and Nutrition Examination Survey (KNHANES), Ministry of Health National Population Health Survey, Malaysian National Health and Morbidity Survey are among the primary and secondary sources referred to while preparing the compression therapy market report.
Table Of Contents
1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
2. Compression Therapy Market Landscape
- 2.1 Overview
- 2.2 Value Chain Analysis
- 2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
- 2.4 Porter's Five Force Analysis
- 2.5 PEST Analysis
- 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
- 2.6.1 Import-Export Analysis for Key Countries
- 2.7 Impact of Artificial Intelligence (AI)
- 2.8 Product or Technology Roadmap
- 2.9 Sustainability and ESG Trends
- 2.10 Patent Analysis
- 2.11 Regulatory Framework
3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Share Analysis, 2025 - By Key Players
- 3.3 Market Concentration
4. Compression Therapy Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.2 Market Restraints
- 4.3 Market Opportunities
- 4.4 Future Trends
- 4.5 Impact of Drivers and Restraints
5. Compression Therapy Market - Global Market Analysis
- 5.1 Compression Therapy Market Revenue (US$ Million), 2021-2034
- 5.2 Compression Therapy Market Forecast and Analysis
6. Compression Therapy Market Revenue Analysis - Product
- 6.1 Compression Therapy Market Forecasts and Analysis by Product
- 6.1.1 Compression Bandages
- 6.1.1.1 Overview
- 6.1.1.2 Compression Bandages: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.2 Compression Wraps
- 6.1.2.1 Overview
- 6.1.2.2 Compression Wraps: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.3 Compression Stockings
- 6.1.3.1 Overview
- 6.1.3.2 Compression Stockings: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.4 Compression Sleeves
- 6.1.4.1 Overview
- 6.1.4.2 Compression Sleeves: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.5 Compression Tape
- 6.1.5.1 Overview
- 6.1.5.2 Compression Tape: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.6 Compression Braces
- 6.1.6.1 Overview
- 6.1.6.2 Compression Braces: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.7 Compression Pumps
- 6.1.7.1 Overview
- 6.1.7.2 Compression Pumps: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.8 Others
- 6.1.8.1 Overview
- 6.1.8.2 Others: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 6.1.1 Compression Bandages
7. Compression Therapy Market Revenue Analysis - Technology
- 7.1 Compression Therapy Market Forecasts and Analysis by Technology
- 7.1.1 Static Compression Therapy
- 7.1.1.1 Overview
- 7.1.1.2 Static Compression Therapy: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 7.1.2 Dynamic Compression Therapy
- 7.1.2.1 Overview
- 7.1.2.2 Dynamic Compression Therapy: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 7.1.1 Static Compression Therapy
8. Compression Therapy Market Revenue Analysis - Application
- 8.1 Compression Therapy Market Forecasts and Analysis by Application
- 8.1.1 Lymphedema
- 8.1.1.1 Overview
- 8.1.1.2 Lymphedema: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 8.1.2 Leg Ulcer
- 8.1.2.1 Overview
- 8.1.2.2 Leg Ulcer: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 8.1.3 Deep Vein Thrombosis
- 8.1.3.1 Overview
- 8.1.3.2 Deep Vein Thrombosis: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 8.1.4 Varicose veins
- 8.1.4.1 Overview
- 8.1.4.2 Varicose veins: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 8.1.5 Lipedema
- 8.1.5.1 Overview
- 8.1.5.2 Lipedema: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 8.1.6 Others
- 8.1.6.1 Overview
- 8.1.6.2 Others: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 8.1.1 Lymphedema
9. Compression Therapy Market Revenue Analysis - End User
- 9.1 Compression Therapy Market Forecasts and Analysis by End User
- 9.1.1 Hospitals and Clinics
- 9.1.1.1 Overview
- 9.1.1.2 Hospitals and Clinics: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 9.1.2 Nursing Care Centers
- 9.1.2.1 Overview
- 9.1.2.2 Nursing Care Centers: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 9.1.3 Home Care Settings
- 9.1.3.1 Overview
- 9.1.3.2 Home Care Settings: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 9.1.4 Others
- 9.1.4.1 Overview
- 9.1.4.2 Others: Compression Therapy Market - Revenue, 2021-2034 (US$ Million)
- 9.1.1 Hospitals and Clinics
10. Compression Therapy Market - Geographical Analysis
- 10.1 North America
- 10.1.1 North America Compression Therapy Market Overview
- 10.1.2 North America: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.3 North America: Compression Therapy Market - By Segmentation
- 10.1.3.1 Product
- 10.1.3.2 Technology
- 10.1.3.3 Application
- 10.1.3.4 End User
- 10.1.4 North America: Compression Therapy Market Breakdown by Countries
- 10.1.4.1 United States Market
- 10.1.4.1.1 United States: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.1.2 United States: Compression Therapy Market - By Segmentation
- 10.1.4.1.2.1 Product
- 10.1.4.1.2.2 Technology
- 10.1.4.1.2.3 Application
- 10.1.4.1.2.4 End User
- 10.1.4.2 Canada Market
- 10.1.4.2.1 Canada: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.2.2 Canada: Compression Therapy Market - By Segmentation
- 10.1.4.2.2.1 Product
- 10.1.4.2.2.2 Technology
- 10.1.4.2.2.3 Application
- 10.1.4.2.2.4 End User
- 10.1.4.3 Mexico Market
- 10.1.4.3.1 Mexico: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.1.4.3.2 Mexico: Compression Therapy Market - By Segmentation
- 10.1.4.3.2.1 Product
- 10.1.4.3.2.2 Technology
- 10.1.4.3.2.3 Application
- 10.1.4.3.2.4 End User
- 10.1.4.1 United States Market
- 10.2 Europe
- 10.2.1 Europe Compression Therapy Market Overview
- 10.2.2 Europe: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.3 Europe: Compression Therapy Market - By Segmentation
- 10.2.3.1 Product
- 10.2.3.2 Technology
- 10.2.3.3 Application
- 10.2.3.4 End User
- 10.2.4 Europe: Compression Therapy Market Breakdown by Countries
- 10.2.4.1 Germany Market
- 10.2.4.1.1 Germany: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.1.2 Germany: Compression Therapy Market - By Segmentation
- 10.2.4.1.2.1 Product
- 10.2.4.1.2.2 Technology
- 10.2.4.1.2.3 Application
- 10.2.4.1.2.4 End User
- 10.2.4.2 United Kingdom Market
- 10.2.4.2.1 United Kingdom: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.2.2 United Kingdom: Compression Therapy Market - By Segmentation
- 10.2.4.2.2.1 Product
- 10.2.4.2.2.2 Technology
- 10.2.4.2.2.3 Application
- 10.2.4.2.2.4 End User
- 10.2.4.3 France Market
- 10.2.4.3.1 France: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.3.2 France: Compression Therapy Market - By Segmentation
- 10.2.4.3.2.1 Product
- 10.2.4.3.2.2 Technology
- 10.2.4.3.2.3 Application
- 10.2.4.3.2.4 End User
- 10.2.4.4 Italy Market
- 10.2.4.4.1 Italy: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.4.2 Italy: Compression Therapy Market - By Segmentation
- 10.2.4.4.2.1 Product
- 10.2.4.4.2.2 Technology
- 10.2.4.4.2.3 Application
- 10.2.4.4.2.4 End User
- 10.2.4.5 Spain Market
- 10.2.4.5.1 Spain: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.5.2 Spain: Compression Therapy Market - By Segmentation
- 10.2.4.5.2.1 Product
- 10.2.4.5.2.2 Technology
- 10.2.4.5.2.3 Application
- 10.2.4.5.2.4 End User
- 10.2.4.6 Rest of Europe Market
- 10.2.4.6.1 Rest of Europe: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.2.4.6.2 Rest of Europe: Compression Therapy Market - By Segmentation
- 10.2.4.6.2.1 Product
- 10.2.4.6.2.2 Technology
- 10.2.4.6.2.3 Application
- 10.2.4.6.2.4 End User
- 10.2.4.1 Germany Market
- 10.3 Asia Pacific
- 10.3.1 Asia Pacific Compression Therapy Market Overview
- 10.3.2 Asia Pacific: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.3 Asia Pacific: Compression Therapy Market - By Segmentation
- 10.3.3.1 Product
- 10.3.3.2 Technology
- 10.3.3.3 Application
- 10.3.3.4 End User
- 10.3.4 Asia Pacific: Compression Therapy Market Breakdown by Countries
- 10.3.4.1 China Market
- 10.3.4.1.1 China: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.1.2 China: Compression Therapy Market - By Segmentation
- 10.3.4.1.2.1 Product
- 10.3.4.1.2.2 Technology
- 10.3.4.1.2.3 Application
- 10.3.4.1.2.4 End User
- 10.3.4.2 Japan Market
- 10.3.4.2.1 Japan: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.2.2 Japan: Compression Therapy Market - By Segmentation
- 10.3.4.2.2.1 Product
- 10.3.4.2.2.2 Technology
- 10.3.4.2.2.3 Application
- 10.3.4.2.2.4 End User
- 10.3.4.3 India Market
- 10.3.4.3.1 India: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.3.2 India: Compression Therapy Market - By Segmentation
- 10.3.4.3.2.1 Product
- 10.3.4.3.2.2 Technology
- 10.3.4.3.2.3 Application
- 10.3.4.3.2.4 End User
- 10.3.4.4 Australia Market
- 10.3.4.4.1 Australia: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.4.2 Australia: Compression Therapy Market - By Segmentation
- 10.3.4.4.2.1 Product
- 10.3.4.4.2.2 Technology
- 10.3.4.4.2.3 Application
- 10.3.4.4.2.4 End User
- 10.3.4.5 South Korea Market
- 10.3.4.5.1 South Korea: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.5.2 South Korea: Compression Therapy Market - By Segmentation
- 10.3.4.5.2.1 Product
- 10.3.4.5.2.2 Technology
- 10.3.4.5.2.3 Application
- 10.3.4.5.2.4 End User
- 10.3.4.6 Rest of APAC Market
- 10.3.4.6.1 Rest of APAC: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.3.4.6.2 Rest of APAC: Compression Therapy Market - By Segmentation
- 10.3.4.6.2.1 Product
- 10.3.4.6.2.2 Technology
- 10.3.4.6.2.3 Application
- 10.3.4.6.2.4 End User
- 10.3.4.1 China Market
- 10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Compression Therapy Market Overview
- 10.4.2 Middle East and Africa: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.3 Middle East and Africa: Compression Therapy Market - By Segmentation
- 10.4.3.1 Product
- 10.4.3.2 Technology
- 10.4.3.3 Application
- 10.4.3.4 End User
- 10.4.4 Middle East and Africa: Compression Therapy Market Breakdown by Countries
- 10.4.4.1 Saudi Arabia Market
- 10.4.4.1.1 Saudi Arabia: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.4.1.2 Saudi Arabia: Compression Therapy Market - By Segmentation
- 10.4.4.1.2.1 Product
- 10.4.4.1.2.2 Technology
- 10.4.4.1.2.3 Application
- 10.4.4.1.2.4 End User
- 10.4.4.2 South Africa Market
- 10.4.4.2.1 South Africa: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.4.2.2 South Africa: Compression Therapy Market - By Segmentation
- 10.4.4.2.2.1 Product
- 10.4.4.2.2.2 Technology
- 10.4.4.2.2.3 Application
- 10.4.4.2.2.4 End User
- 10.4.4.3 United Arab Emirates Market
- 10.4.4.3.1 United Arab Emirates: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.4.3.2 United Arab Emirates: Compression Therapy Market - By Segmentation
- 10.4.4.3.2.1 Product
- 10.4.4.3.2.2 Technology
- 10.4.4.3.2.3 Application
- 10.4.4.3.2.4 End User
- 10.4.4.4 Rest of Middle East and Africa Market
- 10.4.4.4.1 Rest of Middle East and Africa: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.4.4.4.2 Rest of Middle East and Africa: Compression Therapy Market - By Segmentation
- 10.4.4.4.2.1 Product
- 10.4.4.4.2.2 Technology
- 10.4.4.4.2.3 Application
- 10.4.4.4.2.4 End User
- 10.4.4.1 Saudi Arabia Market
- 10.5 South and Central America
- 10.5.1 South and Central America Compression Therapy Market Overview
- 10.5.2 South and Central America: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.5.3 South and Central America: Compression Therapy Market - By Segmentation
- 10.5.3.1 Product
- 10.5.3.2 Technology
- 10.5.3.3 Application
- 10.5.3.4 End User
- 10.5.4 South and Central America: Compression Therapy Market Breakdown by Countries
- 10.5.4.1 Brazil Market
- 10.5.4.1.1 Brazil: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.5.4.1.2 Brazil: Compression Therapy Market - By Segmentation
- 10.5.4.1.2.1 Product
- 10.5.4.1.2.2 Technology
- 10.5.4.1.2.3 Application
- 10.5.4.1.2.4 End User
- 10.5.4.2 Argentina Market
- 10.5.4.2.1 Argentina: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.5.4.2.2 Argentina: Compression Therapy Market - By Segmentation
- 10.5.4.2.2.1 Product
- 10.5.4.2.2.2 Technology
- 10.5.4.2.2.3 Application
- 10.5.4.2.2.4 End User
- 10.5.4.3 Rest of South and Central America Market
- 10.5.4.3.1 Rest of South and Central America: Compression Therapy Market Revenue and Forecasts, 2021-2034 (US$ Million)
- 10.5.4.3.2 Rest of South and Central America: Compression Therapy Market - By Segmentation
- 10.5.4.3.2.1 Product
- 10.5.4.3.2.2 Technology
- 10.5.4.3.2.3 Application
- 10.5.4.3.2.4 End User
- 10.5.4.1 Brazil Market
11. Compression Therapy Market Industry Landscape
12. Compression Therapy Market - Key Company Profiles
- 12.1 Enovis Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Convatec Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Arjo AB
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Paul Hartmann AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Essity AB
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Juzo
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 SIGVARIS GROUP
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Lohmann & Rauscher GmbH & Co KG
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Solventum Corporation
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 medi Canada Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. List of Additional Companies Analyzed
- 13.1 List of Additional Companies Analyzed
14. Appendix
- 14.1 Glossary
- 14.2 Research Methodology and Approach
- 14.2.1 Secondary Research
- 14.2.2 Primary Research
- 14.2.3 Market Estimation Approach
- 14.2.3.1 Supply Side Analysis
- 14.2.3.2 Demand Side Analysis
- 14.2.4 Research Assumptions and Limitations
- 14.2.5 Currency Conversion
- 14.3 About The Insight Partners
- 14.4 Market Intelligence Cloud
